Anti-PI 3 Kinase p85 beta antibody [EPR18416]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(29 Publications)
Rabbit Recombinant Monoclonal PI 3 Kinase p85 beta antibody. Suitable for IP, WB, ICC/IF, IHC-P and reacts with Human, Rat samples. Cited in 29 publications.
View Alternative Names
Phosphatidylinositol 3-kinase regulatory subunit beta, PI3-kinase regulatory subunit beta, PI3K regulatory subunit beta, PtdIns-3-kinase regulatory subunit beta, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta, PI3-kinase subunit p85-beta, PtdIns-3-kinase regulatory subunit p85-beta, PIK3R2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
Immunohistochemical analysis of paraffin-embedded Human colon tissue labeling PI 3 Kinase p85 beta using ab180967 at 1/100 dilution. A Goat Anti-Rabbit IgG H&L (HRP) (ab97051) was used as secondary at 1/500 dilution. Cytoplasm staining on epithelial cells of Human colon was observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (ab180967) at 1/2000 dilution
Lane 1:
Human fetal brain lysate at 10 µg
Lane 2:
Human fetal kidney lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 81 kDa
Observed band size: 82 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (ab180967) at 1/2000 dilution
Lane 1:
HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 20 µg
Lane 3:
HEK293 (Human epithelial cells from embryonic kidney) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 81 kDa
Observed band size: 82 kDa
false
Exposure time: 30s
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized Jurkat (Human T cell leukemia cells from peripheral blood) cells labeling PI 3 Kinase p85 beta with ab180967 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing nuclear and weakly cytoplasmic staining on Jurkat cell line.
The nuclear counter stain is DAPI (blue).
Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows :
1. ab180967 at 1/500 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
2. ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
Immunohistochemical analysis of paraffin-embedded Human colonic adenocarcinoma tissue labeling PI 3 Kinase p85 beta using ab180967 at 1/100 dilution. A Goat Anti-Rabbit IgG H&L (HRP) (ab97051) was used as secondary at 1/500 dilution. Nucleus and cytoplasm staining on tumor cells of colonic adenocarcinoma was observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
Immunohistochemical analysis of paraffin-embedded Rat testis tissue labeling PI 3 Kinase p85 beta using ab180967 at 1/100 dilution. A Goat Anti-Rabbit IgG H&L (HRP) (ab97051) was used as secondary at 1/500 dilution. Nucleus and cytoplasm staining on spermatogenic cell of rat testis was observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling PI 3 Kinase p85 beta with ab180967 at 1/500 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing nuclear and cytoplasmic staining on HeLa cell line.
The nuclear counter stain is DAPI (blue).
Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution (red).
The negative controls are as follows :
1. ab180967 at 1/500 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/1000 dilution.
2. ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/1000 dilution.
- IP
Supplier Data
Immunoprecipitation - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
PI 3 Kinase p85 beta was immunoprecipitated from 1mg of HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate with ab180967 at 1/80 dilution. Western blot was performed from the immunoprecipitate using ab180967 at 1/10000 dilution. Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG, was used as secondary antibody at 1/1500 dilution.
Lane 1 : HeLa whole cell lysate10 μg (Input).
Lane 2 : ab180967 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab180967 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds.
All lanes:
Immunoprecipitation - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (ab180967)
Predicted band size: 81 kDa
false
- WB
Lab
Western blot - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : PIK3R2 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa whole cell lysate (20 μg)
Lanes 1 - 3 : Merged signal (red and green). Green - ab180967 observed at 85 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab180967 was shown to specifically react with PIK3R2 (KO) when PIK3R2 (KO) knockout samples were used. Wild-type and PIK3R2 (KO) knockout samples were subjected to SDS-PAGE. ab180967 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 2000 dilution and 1/10000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (ab180967)
Predicted band size: 81 kDa
false
- WB
Lab
Western blot - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
Lanes 1- 2 : Merged signal (red and green). Green - ab180967 observed at 85 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab180967 was shown to react with PI 3 Kinase p85 beta in wild-type HEK-293T cells in western blot. Loss of signal was observed when knockout cell line ab266799 (knockout cell lysate ab257586) was used. Wild-type HEK-293T and PIK3R2 knockout HEK-293T cell lysates were subjected to SDS-PAGE. ab180967 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 2000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (ab180967) at 1/2000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
PIK3R2 knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human PIK3R2 (PI 3 Kinase p85 beta) knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-pik3r2-pi-3-kinase-p85-beta-knockout-hek-293t-cell-line-ab266799'>ab266799</a>)
Predicted band size: 56 kDa,81 kDa
Observed band size: 56 kDa,85 kDa
false
- WB
Supplier Data
Western blot - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (AB180967)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-PI 3 Kinase p85 beta antibody [EPR18416] (ab180967) at 1/2000 dilution
Lane 1:
Rat brain lysate at 10 µg
Lane 2:
Rat spleen lysate at 10 µg
Lane 3:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 81 kDa
Observed band size: 82 kDa
false
Exposure time: 30s
Related conjugates and formulations (2)
-
Anti-PI 3 Kinase p85 beta antibody [EPR18416] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-PI 3 Kinase p85 beta antibody [EPR18416]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The regulatory subunit PI 3-kinase p85 beta is responsible for maintaining the balance of PI3K activity within the cellular environment. It forms a dynamic complex with the catalytic subunit influencing downstream signaling pathways. The presence of p85 beta ensures the stability and function of the PI3K complex essential for processes such as cell growth survival and metabolism.
Pathways
This protein plays a significant role in the PI3K/AKT/mTOR signaling pathway and also contributes to insulin signaling. It partners with p110 and mediates the transmission of signals from receptor tyrosine kinases (RTKs) like insulin receptors. The regulation by p85 beta affects protein synthesis and glucose uptake highlighting its function in cellular energy management.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (29)
Recent publications for all applications. Explore the full list and refine your search
American journal of cancer research 13:5577-5589 PubMed38058835
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biological & pharmaceutical bulletin 46:382-393 PubMed36385013
2022
Applications
Unspecified application
Species
Unspecified reactive species
Genes and environment : the official journal of the Japanese Environmental Mutagen Society 44:23 PubMed36163195
2022
Applications
Unspecified application
Species
Unspecified reactive species
Chemical biology & drug design 101:24-39 PubMed35730258
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed35628294
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 23:142 PubMed35069823
2022
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 22:e53693 PubMed34661367
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 25:328-341 PubMed34484860
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in genetics 12:596709 PubMed34040629
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:613 PubMed33936270
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Associated Products
Alternative Product
Primary Antibodies
AB28356
Anti-PI 3 Kinase p85 beta antibody [T15]
primary-antibodies
pi-3-kinase-p85-beta-antibody-t15-ab28356
0
(0 reviews)
Alternative Product
Primary Antibodies
AB131067
Anti-PI 3 Kinase p85 beta antibody
primary-antibodies
pi-3-kinase-p85-beta-antibody-ab131067
0
(0 reviews)
Alternative Product
Primary Antibodies
AB138364
Anti-PI 3 Kinase p85 beta (phospho Y464) antibody
primary-antibodies
pi-3-kinase-p85-beta-phospho-y464-antibody-ab138364
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com